Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutamide in PMDD
NCT00611923Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2005
- Primary completion
- Jun 2011
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Premenstrual Dysphoric Disorder (PMDD) comparing Flutamide with Placebo (2 arms). Primary endpoint: Premenstrual Tension Scale at 2 months. Started Feb 2005; status: completed.
02
Drugs
flutamide
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT00611923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611923.